We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
The Cabinet of Ministers of Ukraine, by Resolution No. 1759 dated December 26, 2025, has approved new procedures governing marketing and promotional services in
LA Law Firm is pleased to announce the promotion of Counsel Lidiia Sanzharovska to Associate Partner of the firm, effective January 1, 2025.
As soon as the pharmaceutical market began to recover from the adoption of the new List of OTC medicines prohibited for advertising, the Order of the Ministry of Health No. 1894 dated 02.11.2023 suspended its validity until 1 March 2024. In order to understand the legal implications of these developments, it is important to focus on certain aspects.
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
A webinar on 'Revolutionary changes in the regulation of the pharmaceutical market of Ukraine: UPDATE' was recently held, organised by LA Law Firm, with the Apteka.UA Weekly as the media partner.
LA Law Firm held a webinar "Regulatory changes for pharmaceutical sector in 2024. Conclusions and forecasts". During the event, the participants discussed changes in the Health Technology Assessment procedure, regulation of prices for medicines, the Prozorro Market Electronic Catalogue, regulatory plans to change approaches to the circulation of dietary supplements, etc.
The Law of Ukraine "On Amendments to the Law of Ukraine "On Advertising" No. 3136-IX dated 30.05.2023 updated a number of provisions of the previous version of the Law of Ukraine "On Advertising".